| Literature DB >> 22815916 |
Federico Carlos Blanco1, Marcelo Soria, María Verónica Bianco, Fabiana Bigi.
Abstract
Mycobacterium bovis is the causative agent of most cases of bovine tuberculosis. The identification of bTB biomarkers in specific stages of the disease will contribute to a better understanding of the immunopathology associated with tuberculosis and will enable their use in disease diagnosis and prognosis. The aim of this study was to evaluate the gene expression profile induced after specific stimulation of bovine peripheral blood mononuclear cells from cattle infected with M. bovis using the Affymetrix® GeneChip® Bovine Genome Array. A total of 172 genes showed differential expression profile that was statistically significant with log2-fold change >2.5 and <-2.5. Twenty-four out of these genes were upregulated and 148 were downregulated in bovine peripheral blood mononuclear cells of M. bovis-infected cattle. The highest differentially-expressed genes were related to immune and inflammatory responses, apoptosis, endocytosis, cellular trafficking and genes encoding proteins involved in cellular matrix degradation. Microarray results were confirmed in another group of infected cattle by RT-qPCR for the CD14, IL-1R, THBS1, MMP9 and FYVE genes. This study confirms previous findings that have shown that M. bovis infection in cattle results in the downregulation of immune response-related genes. Moreover, it validates the use of microarray platforms in combination with RT-qPCR to identify biomarkers of bovine tuberculosis. In addition, we propose CD14, IL-1R, THBS1, MMP9 and FYVE as potential biomarkers of bovine tuberculosis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22815916 PMCID: PMC3397951 DOI: 10.1371/journal.pone.0041066
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The most relevant downregulated genes in PBMCs of M. bovis infected cattle.
| Process | Symbol | FC | adj.P.Val | Gene name |
|
| ||||
| MRC1 | −3.303 | 2.564E-13 | Mannose receptor. C type 1 | |
| CXCR2 | −6.235 | 1.888E-11 | Interleukin 8 receptor. Beta | |
| RETN | −6.201 | 9.116E-19 | Resistin | |
| CSF1R | −4.440 | 5.873E-16 | Colony stimulating factor 1 receptor | |
| CCL8 | −4.272 | 6.349E-10 | Chemokine (C-C motif) ligand 8 | |
| CD14 | −4.140 | 1.562E-17 | CD14 molecule. | |
| FCAR | −4.129 | 6.639E-15 | Fc fragment of IgA. receptor | |
| LOC508666 | −3.963 | 1.659E-11 | C-C motif chemokine 23-like | |
| CSF3R | −3.567 | 1.974E-09 | Colony stimulating factor 3 receptor | |
| FCGR1A | −3.446 | 2.094E-15 | Fc fragment of IgG. high affinity Ia. receptor (CD64) | |
| NRP1 | −3.230 | 8.997E-10 | Neuropilin 1 | |
| IL1RN | −3.172 | 2.745E-18 | Interleukin 1 receptor antagonist | |
| CCL2 | −3.050 | 4.864E-18 | Chemokine (C-C motif) ligand 2 | |
| NFAM1 | −3.046 | 7.780E-13 | NFAT activating protein with ITAM motif 1/ | |
| PF4 | −3.038 | 9.815E-17 | Platelet factor 4 (CXC chemokine family) | |
| IL13RA1 | −2.963 | 1.893E-16 | Interleukin 13 receptor. alpha 1 | |
| CCR1 | −2.936 | 4.864E-17 | Chemokine (C-C motif) receptor 1 | |
|
| ||||
| TGM3 | −6.978 | Transglutaminase 3 | ||
| TGFBI | −4.198 | 4.277E-10 | TGF-β: Transforming growth factor beta | |
| TREM1 | −4.011 | 3.437E-17 | Triggering receptor expressed on myeloid cells | |
| PYCARD | −3.876 | 5.531E-16 | PYD and CARD domain | |
| IL1R1 | −3.866 | 8.108E-17 | PYD and CARD domain | |
| HAS2 | −3.663 | 2.858E-10 | Hyaluronan synthase 2 | |
|
| ||||
| MMP9 | −5.390 | 5.689E-18 | Matrix metallopeptidase 9 | |
| ECM1 | −4.307 | 1.548E-16 | Extracellular matrix protein 1 | |
| MMP3 | −4.302 | 4.349E-15 | Matrix metallopeptidase 3 | |
| ADAM8 | −3.811 | 5.152E-17 | ADAM metallopeptidase domain 8 | |
| MMP19 | −3.599 | 1.075E-13 | Matrix metallopeptidase 19 | |
| ADAMTSL4 | −3.027 | 1.701E-16 | Metalloproteinase with thrombospondin motifs | |
|
| ||||
| SASH1 | −4.934 | 1.167E-15 | SAM and SH3 domain | |
| SH3BP4 | −3.239 | 1.338E-13 | SH3-domain binding protein 4 | |
| VLDLR | −4.210 | 2.367E-17 | Very low density lipoprotein receptor | |
| LOC533894 | −4.154 | 3.107E-16 | Low density lipoprotein receptor-related protein 1 | |
| S100A9 | −3.967 | 1.992E-17 | S100 calcium binding protein A9 | |
| ARHGAP21 | −3.467 | 4.185E-16 | Rho GTPase activating protein 21 | |
|
| ||||
| AREGB | −5.237 | 4.723E-13 | Amphiregulin B (epidermal growth factor family) | |
| PLAUR | −3.134 | 7.737E-17 | Plasminogen activator. urokinase receptor | |
FC: log2-fold change.
The most relevant upregulated genes in PBMCs of M. bovis infected cattle.
| Process | Symbol | FC | adj.P.Val | Gene name |
|
| IFNG | 4.972 | 3.600E-13 | Interferon gamma |
| BLA-DQB | 4.049 | 3.238E-11 | MHC class II antigen | |
| IL2 | 3.347 | 9.539E-14 | Interleukin 2 | |
| IL3 | 2.994 | 9.771E-13 | Interleukin 3 | |
| BOLA-DQA1 | 2.961 | 3.526E-09 | Major histocompatibility complex class II. | |
| NOLC1 | 4.030 | 4.094E-17 | Nucleolar and coiled-body phosphoprotein 1 | |
|
| PSPH | 2.974 | 3.257E-13 | Phosphoserine phosphatase |
FC: log2-fold change.
Differential pathways between PBMC from M. bovis-infected animals and control animals using GSEA.
| Downregulated pathways | ||
|
|
|
|
| 04010 | MAPK signaling pathway |
|
| 04142 | Lysosome |
|
| 04144 | Endocytosis |
|
| 04145 | Phagosome |
|
| 04722 | Neurotrophin signaling pathway |
|
| 04810 | Regulation of actin cytoskeleton |
|
| 05140 | Leishmaniasis |
|
|
| ||
|
|
|
|
| 00190 | Oxidative phosphorylation |
|
| 00230 | Purine metabolism |
|
| 01100 | Metabolic pathways |
|
| 03040 | Spliceosome |
|
| 04660 | T cell receptor signaling pathway |
|
| 05012 | Parkinson’s disease |
|
| 05016 | Huntington’s disease |
|
| 05200 | Pathways in cancer |
|
The differential pathways were assessed with the gseattperm function in the Category Bioconductor package (10,000 permutations). All the pathways shown were significant at a P<0.01, adjusted for multiple comparisons using the false discovery rate method.
Figure 1Gene expression fold-change differences between PBMC from M. bovis-infected animals (n = 8) and control animals (n = 8) using RT-qPCR.
Relative gene expression was calculated using the 2-ΔΔCt method with E correction, using gadph mRNA expression as reference gene and the preimmune condition as the calibrator. Data were analyzed using a two-tailed unpaired t test (*p<0.05, **p<0.005). The bars indicate the average ratios of infected animals/uninfected animals ± SEM.